Max Wilberding
Impact in
-
- Pancreatic and Hepatic Oncology Research
-
- Fibroblast Growth Factor Research
- Epigenetics and DNA Methylation
- Kruppel-like factors research
Papers in
- Surgery 4
- Enhanced Recovery After Surgery 2
- Cholangiocarcinoma and Gallbladder Cancer Studies 2
-
- Fibroblast Growth Factor Research 3
- Kruppel-like factors research 1
- Chromatin Remodeling and Cancer 1
- Co-authors
- Julie W. Reeser (3 shared papers)Hui‐Zi Chen (3 shared papers)Melanie A. Krook (3 shared papers)Sameek Roychowdhury (3 shared papers)Gabrielle Ernst (1 shared paper)Gary Li (1 shared paper)Kelly M. Bailey (1 shared paper)Michele R. Wing (2 shared papers)
- Journals
- Molecular Cancer Therapeutics (1 paper)British Journal of Cancer (1 paper)Journal of Surgical Research (1 paper)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- United States
In The Last Decade
Max Wilberding
5 papers receiving 321 citations
Hit Papers
Peers
Comparison fields: 5 of 49
- Oncology 101
- Molecular Biology 226
- Surgery 139
- Cancer Research 47
- Rheumatology 47
Countries citing papers authored by Max Wilberding
This map shows the geographic impact of Max Wilberding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Wilberding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Wilberding more than expected).
Fields of papers citing papers by Max Wilberding
This network shows the impact of papers produced by Max Wilberding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Wilberding. The network helps show where Max Wilberding may publish in the future.
Co-authors
The 24 scholars most cited alongside Max Wilberding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance Hit paper breakdown → | 2020 | 213 |
| 2 | 2020 | 106 | |
| 3 | 2023 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2019 | 1 |
About Max Wilberding
Max Wilberding is a scholar working on Surgery, Molecular Biology, Cardiology and Cardiovascular Medicine, Sociology and Political Science and Pulmonary and Respiratory Medicine, having authored 5 papers that have together received 324 indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (3 papers), Cardiac, Anesthesia and Surgical Outcomes (2 papers), Enhanced Recovery After Surgery (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Kruppel-like factors research (1 paper), Delphi Technique in Research (1 paper), Chromatin Remodeling and Cancer (1 paper) and Metastasis and carcinoma case studies (1 paper). The work is most often cited by research in Oncology (101 citations), Molecular Biology (226 citations), Surgery (139 citations), Cancer Research (47 citations) and Rheumatology (47 citations). Max Wilberding has collaborated with scholars based in United States. Frequent co-authors include Julie W. Reeser, Hui‐Zi Chen, Melanie A. Krook, Sameek Roychowdhury, Gabrielle Ernst, Gary Li, Kelly M. Bailey, Michele R. Wing, Aharon G. Freud and Amy Smith. Their work appears in journals such as Molecular Cancer Therapeutics, British Journal of Cancer, Journal of Surgical Research and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.